The evolution of technology-based alliance networks in pharmaceutical biotechnology

V.A. Gilsing, M.M.A.H. Cloodt, A.H.W.M. Roijakkers

Research output: Chapter in Book/Report/Conference proceedingConference contributionAcademicpeer-review


The dominant focus in the literature until now has been on how networks enable and constrain action, whereas the question what factors enable and constrain networks has been largely ignored. To fill this void, the paper aims to develop an understanding of the role of ex-ante factors and processes that influence network evolution. Empirically, we study network evolution in the biotechnology industry along two levels of analysis: network and dyad level. One of the key findings is that these two levels seem to change relatedly in response to exogenous environmental change. More generally, our framework contributes by elucidating not only how networks evolve, but also why they evolve in ways they do. Overall, this yields valuable insights that carry implications for the literature on learning and innovation, strategic alliances as well as on social network theory.
Original languageEnglish
Title of host publicationProceedings of the 24th European Group for Organizational Studies (EGOS) Conference
Place of PublicationAmsterdam, the Netherlands
PublisherVrije Universiteit Amsterdam
Publication statusPublished - 2008
Eventconference; 24th annual meeting; 2008-07-10; 2008-07-12 -
Duration: 10 Jul 200812 Jul 2008


Conferenceconference; 24th annual meeting; 2008-07-10; 2008-07-12
Other24th annual meeting


Dive into the research topics of 'The evolution of technology-based alliance networks in pharmaceutical biotechnology'. Together they form a unique fingerprint.

Cite this